Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16172
Title: The genetic landscape of the epileptic encephalopathies of infancy and childhood
Austin Authors: McTague, Amy;Howell, Katherine B;Cross, J Helen;Kurian, Manju A;Scheffer, Ingrid E 
Affiliation: Austin Health, Heidelberg, Victoria, Australia
Molecular Neurosciences, Developmental Neurosciences Programme, UCL Institute of Child Health, London, UK
Clinical Neurosciences, Developmental Neurosciences Programme, UCL Institute of Child Health, London, UK
Department of Neurology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
Department of Neurology, Royal Children's Hospital, Melbourne, Victoria, Australia
Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia
Neurosciences Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia
Department of Medicine, Epilepsy Research Centre, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia
Florey Institute of Neurosciences and Mental Health, Melbourne, Victoria, Australia
Issue Date: Mar-2016
metadata.dc.date: 2015-11-17
Publication information: Lancet Neurology 2016; 15(3): 304-316
Abstract: Epileptic encephalopathies of infancy and childhood comprise a large, heterogeneous group of severe epilepsies characterised by several seizure types, frequent epileptiform activity on EEG, and developmental slowing or regression. The encephalopathies include many age-related electroclinical syndromes with specific seizure types and EEG features. With the molecular revolution, the number of known monogenic determinants underlying the epileptic encephalopathies has grown rapidly. De-novo dominant mutations are frequently identified; somatic mosaicism and recessive disorders are also seen. Several genes can cause one electroclinical syndrome, and, conversely, one gene might be associated with phenotypic pleiotropy. Diverse genetic causes and molecular pathways have been implicated, involving ion channels, and proteins needed for synaptic, regulatory, and developmental functions. Gene discovery provides the basis for neurobiological insights, often showing convergence of mechanistic pathways. These findings underpin the development of targeted therapies, which are essential to improve the outcome of these devastating disorders.
URI: http://ahro.austin.org.au/austinjspui/handle/1/16172
DOI: 10.1016/S1474-4422(15)00250-1
ORCID: 0000-0002-2311-2174
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/26597089
Type: Journal Article
Subjects: Brain Diseases
Epilepsy
Appears in Collections:Journal articles

Show full item record

Page view(s)

4
checked on Dec 2, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.